Literature DB >> 10747869

Analysis of transcription of the Col6a1 gene in a specific set of tissues suggests a new variant of enhancer region.

D Girotto1, C Fabbro, P Braghetta, P Vitale, D Volpin, G M Bressan.   

Abstract

The region extending from -5.4 to -3.9 kilobase pairs from the transcription start site of the Col6a1 gene has been previously shown to contain sequences activating tissue-specific transcription in articular cartilage, intervertebral disks, subepidermal, and vibrissae mesenchyme and peripheral nervous system (Braghetta, P., Fabbro, C., Piccolo, S., Marvulli, D., Bonaldo, P., Volpin, D., and Bressan, G. M. (1996) J. Cell Biol. 135, 1163-1177). Analysis of expression of deletions of this region in transgenic mice has identified the 383-base pair fragment E-L as the most active sequence of the region. Linker-scanning mutagenesis analysis of segment E-J, which spans the 5' 245 base pairs of E-L and is sufficient for high frequency expression in articular cartilage, showed that all the mutations reduced transcription considerably, suggesting that the integrity of the entire cluster of elements is necessary for enhancer activity. Electrophoretic mobility shift assays with nuclear extracts derived from various sources showed that fragment E-J binds numerous transcription factors (at least 22). These factors are present in most cells, expressing and nonexpressing alpha1(VI) collagen mRNA, but in different relative proportions, and none of them appears to be cell type-specific. Several lines of evidence indicate that sequence elements of the enhancer may have different functional roles in various cells. The data configure the -5.4/-3.9 region of the Col6a1 gene as a new type of tissue-specific enhancer, characterized by a variety of tissues supporting its activation and by the dependence of its function only on ubiquitous transcription factors. This type of enhancer is postulated to be particularly important for genes such as those of the extracellular matrix, which are often expressed with broad tissue specificity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747869     DOI: 10.1074/jbc.M000075200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Poly(2-substituted-2-oxazoline) surfaces for dermal fibroblasts adhesion and detachment.

Authors:  Andrzej Dworak; Alicja Utrata-Wesołek; Natalia Oleszko; Wojciech Wałach; Barbara Trzebicka; Jacek Anioł; Aleksander L Sieroń; Agnieszka Klama-Baryła; Marek Kawecki
Journal:  J Mater Sci Mater Med       Date:  2014-01-04       Impact factor: 3.896

2.  ColVI myopathies: where do we stand, where do we go?

Authors:  Valérie Allamand; Laura Briñas; Pascale Richard; Tanya Stojkovic; Susana Quijano-Roy; Gisèle Bonne
Journal:  Skelet Muscle       Date:  2011-09-23       Impact factor: 4.912

Review 3.  Collagen VI in healthy and diseased nervous system.

Authors:  Ilaria Gregorio; Paola Braghetta; Paolo Bonaldo; Matilde Cescon
Journal:  Dis Model Mech       Date:  2018-05-31       Impact factor: 5.758

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.